Thirty Madison is a health and pharmaceutical startup, founded in 2017, with a mission to address critical healthcare challenges such as access, affordability, patient outcomes, and experience. The company's slogan, "Thirty Madison is a family of specialized healthcare brands creating exceptional outcomes for all," reflects its commitment to delivering exceptional healthcare solutions. With a focus on empathy and innovation, Thirty Madison's proprietary care model provides accessible and effective treatments for hundreds of thousands of individuals with chronic conditions. Its recent Series C funding round on 02 June 2021 secured a significant $140.00M, with notable investors including HealthQuest Capital, Greycroft, Northzone, Polaris Partners, Mousse Partners, SandHill Angels, Bracket Capital, Atacama Ventures, Alpha Partners, and Johnson & Johnson Innovation – JJDC. For more information, visit ThirtyMadison.com.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Funding Round | $1.25M | 1 | Victor Koch | 20 Apr 2024 |
Series C | $140.00M | 10 | Johnson & Johnson Innovation – JJDC | 02 Jun 2021 |
Series B | $47.00M | 6 | Johnson & Johnson Innovation – JJDC | 14 Aug 2020 |
Debt Financing | $18.50M | - | 01 Jan 2020 | |
Series A | $15.25M | 8 | Steadfast Capital Management, Blue Ivy Ventures | 16 Oct 2018 |
No recent news or press coverage available for Thirty Madison.